Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher P Duggan, MD
Harvard School of Public Health (HSPH) and Boston Children's Hospital
Principal Investigator - Christopher R Sudfeld, ScD
Harvard School of Public Health (HSPH)
Principal Investigator - Karim P Manji, MD
Muhimbili University of Health and Allied Sciences
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Muhimbili University of Health and Allied Sciences
Dar es Salaam, Tanzania
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Dec 2024
- Primary completion
- 30 Oct 2027
- Completion
- 30 Oct 2027
- Last update posted
- 12 Dec 2025
- Registered enrollment
- 3,250
- Registry id
- NCT06102044
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.